LOADING
Comparing Exxon Mobil Corporation (XOM) and Merck & Company (MRK) across the Energy and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | XOM | MRK |
|---|---|---|
| Price | $143.37 | $123.72 |
| Change Today | -1.19% | +2.43% |
| Market Cap | $575.7B | $305.1B |
| P/E Ratio | 23.4 | 34.8 |
| Forward P/E | 12.3 | 24.4 |
| PEG Ratio | 1.15 | 6.10 |
| EPS | $5.94 | $3.55 |
| Revenue Growth (YoY) | 2.6% | 4.9% |
| Profit Margin | 7.8% | 13.6% |
| Return on Equity | 9.9% | 18.9% |
| Dividend Yield | 2.94% | 2.62% |
| Beta | 0.16 | 0.20 |
| 52-Week High | $175.22 | $130.29 |
| 52-Week Low | $102.27 | $74.18 |
| Volume | 268K | 150K |
Exxon Mobil Corporation is the larger company by market capitalization. Exxon Mobil Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Exxon Mobil Corporation offers a higher dividend yield for income investors. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.